Associated clinical and laboratory markers of donor on allograft function after heart transplant

Renato Braulio, Marcelo Dias Sanches, Antonio Lúcio Teixeira Junior, Paulo Henrique Nogueira Costa, Maria Da Consolação Vieira Moreira, Monaliza Angela Rocha, Silvio Amadeu De Andrade, Cláudio Léo Gelape

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Introduction: Primary graft dysfunction is a major cause of mortality after heart transplantation. Objective: To evaluate correlations between donor-related clinical/ biochemical markers and the occurrence of primary graft dysfunction/ clinical outcomes of recipients within 30 days of transplant. Methods: The prospective study involved 43 donor/recipient pairs. Data collected from donors included demographic and echocardiographic information, noradrenaline administration rates and concentrations of soluble tumor necrosis factor receptors (sTNFR1 and sTNFR2), interleukins (IL-6 and IL-10), monocyte chemoattractant protein-1, C-reactive protein and cardiac troponin I. Data collected from recipients included operating, cardiopulmonary bypass, intensive care unit and hospitalization times, inotrope administration and left/right ventricular function through echocardiography. Results: Recipients who developed moderate/severe left ventricular dysfunction had received organs from significantly older donors (P=0.020). Recipients from donors who required moderate/high doses of noradrenaline (>0.23 μg/kg/min) around harvesting time exhibited lower post-transplant ventricular ejection fractions (P=0.002) and required longer CPB times (P=0.039). Significantly higher concentrations of sTNFR1 (P=0.014) and sTNFR2 (P=0.030) in donors were associated with reduced intensive care unit times (≤5 days) in recipients, while higher donor IL-6 (P=0.029) and IL-10 (P=0.037) levels were correlated with reduced hospitalization times (≤25 days) in recipients. Recipients who required moderate/high levels of noradrenaline for weaning off cardiopulmonary bypass were associated with lower donor concentrations of sTNFR2 (P=0.028) and IL-6 (P=0.001). Conclusion: High levels of sTNFR1, sTNFR2, IL-6 and IL-10 in donors were associated with enhanced evolution in recipients. Allografts from older donors, or from those treated with noradrenaline doses >0.23 μg/kg/min, were more frequently affected by primary graft dysfunction within 30 days of surgery.

Original languageEnglish (US)
Pages (from-to)89
Number of pages1
JournalBrazilian Journal of Cardiovascular Surgery
Issue number2
StatePublished - Mar 1 2016
Externally publishedYes


  • Biomarkers
  • Heart transplantation
  • Norepinephrine
  • Primary graft dysfunction
  • Tissue donors

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Associated clinical and laboratory markers of donor on allograft function after heart transplant'. Together they form a unique fingerprint.

Cite this